BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/25/2021 8:01:44 AM | Browse: 577 | Download: 1051
 |
Received |
|
2021-01-06 14:38 |
|
Peer-Review Started |
|
2021-01-06 14:39 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-14 06:31 |
|
Revised |
|
2021-02-25 08:24 |
|
Second Decision |
|
2021-03-15 13:14 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-03-16 04:05 |
|
Articles in Press |
|
2021-03-16 04:05 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-03-27 01:34 |
|
Typeset the Manuscript |
|
2021-04-12 07:14 |
|
Publish the Manuscript Online |
|
2021-04-25 08:01 |
| ISSN |
2644-3236 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Clinical value of artificial intelligence in hepatocellular carcinoma: Current status and prospect
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Peng-Sheng Yi, Chen-Jun Hu, Chen-Hui Li and Fei Yu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Project of science and Technology Department of Sichuan Province |
2018JY050 |
| Nanchong Science and Technology Bureau Project |
18SXHZ0336 |
|
| Corresponding Author |
Fei Yu, MD, Professor, Department of Radiology, Yingshan County People's Hospital, No. 100 Danan Street, Yingshan County, Nanchong 610041, Sichuan Province, China. 358496734@qq.com |
| Key Words |
Hepatocellular carcinoma; Artificial intelligence; Diagnosis; Prognosis; Therapy; Genomic |
| Core Tip |
We performed electronic searching in PubMed, Web of Science and EMBASE. Artificial intelligence (AI) or in-depth learning and hepatocellular carcinoma (HCC) were used as mesh terms. We found that AI showed favorable results in early diagnosis and treatment response prediction and prognosis estimation in patients with HCC. The past decade has seen rapid advancements in AI, underlying its unique usefulness in almost every field, including that of medicine. Herein, we sought and reviewed studies and we expect that AI will be an important complementary of traditional routine in diagnosis, treatment, and prognosis estimation of HCC. |
| Publish Date |
2021-04-25 08:01 |
| Citation |
Yi PS, Hu CJ, Li CH, Yu F. Clinical value of artificial intelligence in hepatocellular carcinoma: Current status and prospect. Artif Intell Gastroenterol 2021; 2(2): 42-55 |
| URL |
https://www.wjgnet.com/2644-3236/full/v2/i2/42.htm |
| DOI |
https://dx.doi.org/10.35712/aig.v2.i2.42 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
